Corona Remedies shares jump over 38% on debut

• Corona Remedies shares debuted with over a 38% premium on Monday.
• The stock listed at Rs 1,452 on BSE, a 36.72% jump from its issue price of Rs 1,062.
• The company's market valuation reached Rs 8,996.65 crore after its strong debut.
• Corona Remedies' Initial Public Offering (IPO) was subscribed 137.04 times.
• Headquartered in Ahmedabad, Corona Remedies is a pharma firm specializing in women's healthcare, cardio-diabeto, and other therapeutic areas.

Why It Matters: Corona Remedies' strong market debut reflects high investor confidence.